Vanguard Capital Management’s Olema Oncology OLMA Stock Holding History
Bought
Maintained
Sold
Other funds holding OLMA
SL
Vanguard Capital Management's OLMA Position: Q3 2026 in Review
Vanguard Capital Management increased its Olema Oncology (OLMA) stake by 5.1% in Q3 2026, buying an estimated $1.87M and bringing the position to 3,513,193 shares worth $30.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2174.
Vanguard Capital Management first reported a position in OLMA in Q1 2026 and has held it in 3 quarters since. The position peaked at $46M in Q1 2026. 179 funds tracked by Wall St. Rank hold OLMA as of Q3 2026.
- Vanguard Capital Management held 3,513,193 shares of Olema Oncology worth $30.4M as of Q3 2026.
- Vanguard Capital Management bought 171,976 Olema Oncology shares in Q3 2026, an estimated $1.87M.
- Olema Oncology made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2174 holding.
- Vanguard Capital Management first reported a position in Olema Oncology in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Olema Oncology position peaked at $46M in Q1 2026.
- 179 funds tracked by Wall St. Rank held Olema Oncology as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.